Literature DB >> 6319153

In vitro stimulated lymphocytes as a source of human hybridomas.

D Kozbor, J C Roder.   

Abstract

Stimulation of peripheral blood lymphocyte (PBL) cultures from tetanus toxoid (TT)-immunized donor with Epstein-Barr virus (EBV) yielded cells with much higher frequencies of hybrid formation (36 X 10(-7) compared to unstimulated PBL or cells cultured with pokeweed mitogen or TT antigen. The proportion of hybridomas (approximately 1%) producing anti-TT antibody was similar in EBV- and TT-stimulated cultures. A marked increase in immunoglobulin secretion was observed after hybridization and preselection of EBV subcultures for high anti-TT production prior to fusion resulted in a fivefold increase in TT-specific hybridomas (p less than 0.001). Most (20/21) specific hybrids produced IgM anti-TT, whereas one (1/21) produced IgG anti-TT, possibly due to the immature stage of differentiation in EBV-stimulated parental cells. The ability to choose an antigen, immunize a human subject and expand the rare antigen-specific B cells from PBL, in vitro, with EBV, prior to fusion, should yield an increasing spectrum of human monoclonal antibodies for diagnostic, therapeutic or basic studies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319153     DOI: 10.1002/eji.1830140105

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Development of human monoclonal antibodies: A review.

Authors:  T Lindl
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.

Authors:  Xiaocong Yu; Patricia A McGraw; Frances S House; James E Crowe
Journal:  J Immunol Methods       Date:  2008-05-05       Impact factor: 2.303

Review 3.  Human monoclonal antibodies: methods of production and some aspects of their application in oncology.

Authors:  L Olsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  Establishment and characterization of monoclonal antibodies against SARS coronavirus.

Authors:  Kazuo Ohnishi
Journal:  Methods Mol Biol       Date:  2008

Review 5.  Hybridoma technology: new developments of practical interest.

Authors:  S R Samoilovich; C B Dugan; A J Macario
Journal:  J Immunol Methods       Date:  1987-08-03       Impact factor: 2.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.